echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Annals of Neurology: Actigraphy enables home screening for REM behavioral disorders in Parkinson's disease

    Annals of Neurology: Actigraphy enables home screening for REM behavioral disorders in Parkinson's disease

    • Last Update: 2022-10-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Rapid eye movement sleep behavior disorder (RBD) is a sleep disorder
    that affects up to 70% of people with Parkinson's disease (PD).
    People with RBD exhibit motor and dream-making behaviors during sleep, which can be violent, sometimes violent, and harmful
    .
    Diagnosing and treating RBD is critical to
    preventing serious injuries to patients and their bed partners.

     

    Figure 1: Cover image of the paper


    Isolated RBD represents the early stages of PD or other synaptic proteinopathy and may appear
    years before the more pronounced clinical manifestations of these disorders.
    Its early diagnosis provides a unique window into evaluating the disease-changing effects
    of upcoming treatments.
    In addition, the PD phenotype associated with RBD tends to be more aggressive and exhibits more motor complications
    .
    They are also more often accompanied by symptoms of
    cognitive, behavioral, and autonomic disorders.
    Therefore, identifying RBD in PD can provide fundamental insights that inform clinical practice
    from a therapeutic and prognostic perspective.
    RBD associated with synaptic protein disease remains neglected and under-recognized, even
    among movement disorder specialists.
    Awareness of RBD among the general population and healthcare workers still needs to be improved
    .
    Diagnosing RBD requires nighttime video polysomnography (VPSG), an expensive, time-consuming test that can only be performed by specialized centers, and is a burden
    on patients.
    Current screening tools rely on questionnaires or interviews
    .
    These methods are often subjective and may not be available to people living in the community, or require the presence
    of a bed companion.
    In PD patients, their reliability in capturing RBD is not well proven
    .


    Although RBD behavior is known to be more blunt and violent than that observed in PD patients while awake, there has been no objective and systematic description
    .
    In addition to PSG, the lack of objective measures limits the development of
    screening tools for diagnosing RBD in the context of daily living.
    To better understand the manifestations of RBD and how it changes over time, and to assess efficacy in clinical trials and clinical routines, home screening will be a major tool
    .


    The wrist kinesimeter is a promising RBD screening tool
    .
    In a recent study, visual analysis of motion recordings using pattern recognition could distinguish idiopathic RBD from other motor activities during sleep and identify isolated RBD subjects
    in the general population.
    In this study, they comprehensively described the motor characteristics of RBD from wrist behavioral signals and extracted those features that best distinguished RBD from non-RBD PD patients
    .
    A novel, convenient, at-home RBD screening method
    was then designed and validated.
    Combining action map technology and machine learning algorithms, it is optimized in a controlled clinical environment and translated into a home environment
    .
    Finally, the method validated accuracy at home in non-PD patients with insomnia, either alone or associated with other sleep disorders, and without a history of
    RBD.

    In this way, Flavio Raschellà and others of Onera Health in Eindhoven, the Netherlands, explored that rapid eye movement sleep behavior disorder (RBD) is a potentially harmful and often overlooked sleep disorder that affects up to 70% of people with
    Parkinson's disease.
    Current diagnostics rely on nighttime video polysomnography, an expensive and cumbersome test that requires specific clinical expertise
    .
    They explored the use of wrist behavior to achieve automatic diagnosis
    of RBD in the home environment.


    Twenty-six Parkinson's patients underwent a two-week home wrist force map followed by two evaluations
    in the lab.
    Patients were divided into RBD and non-RBD
    based on dream promulgation history and video polysomnography.
    They used behavioral mapping signals to comprehensively describe the patient's movement patterns
    during sleep.
    A machine learning classification algorithm was then trained to distinguish patients
    with or without RBD with the most relevant features.
    The classification performance of laboratory and home records was quantified
    for clinical diagnosis.
    Performance
    was further validated in a control group consisting of non-PD patients with other sleep disorders.

    To determine the characteristics of RBD, behavioral characteristics extracted from (i) individual motor events and (ii) overall nocturnal activity are key
    .
    Patients with RBD are generally more active and exhibit shorter, more amplitude, and more dispersed exercise times
    .

    Figure 2: Graph of paper results

    Using these features, their classification algorithm achieved an accuracy of 92.
    9±8.
    16% in clinical tests
    .
    When home recordings from Parkinson's disease patients were verified, the accuracy was 100% over a two-week period and 94.
    4%
    in non-Parkinson's control patients.
    These characteristics show robustness
    under different tests and conditions.


    The significance of the study lies in its findings: opening up new prospects for faster, cheaper and more regular screening for sleep disorders, both in routine clinical practice and in clinical trials
    .



    Raschellà F, Scafa S, Puiatti A, Martin Moraud E, Ratti P.
    Actigraphy enables home screening of REM behavior disorder in Parkinson disease.
    _Annals of Neurology_.
    Published online October 4, 2022:ana.
    26517.
    doi:[10.
    1002/ana.
    26517](https://doi.
    org/10.
    1002/ana.
    26517)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.